COMPANY CONTACTMr. Derek T. WelchChief Financial Officer978-345-5000
FITCHBURG, Mass., June 01, 2016 (GLOBE NEWSWIRE) -- Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the "Company"), through its wholly-owned subsidiary, Micron Products, Inc., a diversified contract manufacturing organization that produces highly-engineered, innovative medical device components requiring precision machining and injection molding, announced the results of shareholder voting that took place during the Company's 2016 annual meeting, which was held on May 26, 2016. The shareholders reelected Dr. Paul F. Walter and Mr. Marco F. Benedetti to the Board of Directors for three-year terms. Shareholders also voted to approve the advisory "say on pay" resolution, supporting the compensation plan for the executive officers. Additionally, shareholders ratified the appointment of Wolf & Company, P.C. as independent auditors for 2016. The Company also announced the election of Mr. Jason R. Chambers as Chairman of the Board, effective June 2, 2016. Mr. Chambers has been a member of the Board of Directors since 2006. Former Chairman, Dr. Paul F. Walter will stay on as a Director, serving on the Nominating and Corporate Governance, and Compensation committees. Mr. Chambers stated, "I am honored to become Chairman of the Board. The Company has focused its growth strategy on expanding its overall share of the contract manufacturing services industry, particularly within the medical devices and components market. I am confident we have the leadership and vision to ensure continued momentum and success. On behalf of the Board and executive management, I extend our appreciation to Dr. Walter for serving as our Chairman over the last year and continuing as a Director going forward." About Arrhythmia Research Technology, Inc. Arrhythmia Research Technology, Inc., through its wholly-owned subsidiary, Micron Products, Inc., is a diversified contract manufacturing organization that produces highly-engineered, innovative medical device components requiring precision machining and injection molding. The Company also manufactures components, devices and equipment for military, law enforcement, industrial and automotive applications. In addition, the Company is a market leader in the production and sale of silver/silver chloride coated and conductive resin sensors used as consumable component parts in the manufacture of integrated disposable electrophysiological sensors. The Company's strategy for growth is to build a best-in-class contract manufacturer with a specialized focus on plastic injection molding and highly-engineered medical devices and components requiring precision machining.